Athersys
ATHX
#10565
Rank
โ‚ฌ0.7 M
Marketcap
0,01139ย โ‚ฌ
Share price
-33.50%
Change (1 day)
-99.05%
Change (1 year)

EPS for Athersys (ATHX)

EPS in 2023 (TTM): -1,88ย โ‚ฌ

According to Athersys's latest financial reports the company's current EPS (TTM) is -1,71ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,51ย โ‚ฌ a decrease over its 2021 EPS that were of -1,75ย โ‚ฌ.

EPS history for Athersys from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,88ย โ‚ฌ-65.88%
2022-5,51ย โ‚ฌ213.94%
2021-1,75ย โ‚ฌ395.24%
2020-0,35ย โ‚ฌ44.83%
2019-0,24ย โ‚ฌ61.11%
2018-0,15ย โ‚ฌ-37.93%
2017-0,24ย โ‚ฌ70.59%
2016-0,14ย โ‚ฌ-19.05%
2015-0,18ย โ‚ฌ-25%
2014-0,24ย โ‚ฌ
2012-0,41ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
8,81ย โ‚ฌ-614.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,45ย โ‚ฌ-184.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
10,99ย โ‚ฌ-741.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,13ย โ‚ฌ-282.55%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,41ย โ‚ฌ-474.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,51ย โ‚ฌ-246.31%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
3,85ย โ‚ฌ-324.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-6,81ย โ‚ฌ 297.54%๐Ÿ‡บ๐Ÿ‡ธ USA